Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 179

1.

Expression of galectin-3 in normal and malignant thyroid tissue by quantitative PCR and immunohistochemistry.

Feilchenfeldt J, Tötsch M, Sheu SY, Robert J, Spiliopoulos A, Frilling A, Schmid KW, Meier CA.

Mod Pathol. 2003 Nov;16(11):1117-23.

2.

Expression of Galectin-3 and Galectin-7 in thyroid malignancy as potential diagnostic indicators.

Than TH, Swethadri GK, Wong J, Ahmad T, Jamil D, Maganlal RK, Hamdi MM, Abdullah MS.

Singapore Med J. 2008 Apr;49(4):333-8.

3.

Differential expression of S100C in thyroid lesions.

Torres-Cabala C, Panizo-Santos A, Krutzsch HC, Barazi H, Namba M, Sakaguchi M, Roberts DD, Merino MJ.

Int J Surg Pathol. 2004 Apr;12(2):107-15.

PMID:
15173915
4.

Diagnostic value of galectin-3 as a marker for malignancy in follicular patterned thyroid lesions.

Oestreicher-Kedem Y, Halpern M, Roizman P, Hardy B, Sulkes J, Feinmesser R, Stern Y.

Head Neck. 2004 Nov;26(11):960-6.

PMID:
15386597
5.

Thyroid peroxidase and galectin-3 immunostaining in differentiated thyroid carcinoma with clinicopathologic correlation.

Savin S, Cvejic D, Isic T, Paunovic I, Tatic S, Havelka M.

Hum Pathol. 2008 Nov;39(11):1656-63. doi: 10.1016/j.humpath.2008.04.006. Epub 2008 Jul 26.

PMID:
18657294
6.

Ubiquitous expression of galectin-3 mRNA in benign and malignant thyroid tumors.

Takano T, Miyauchi A, Matsuzuka F, Yoshida H, Kuma K, Amino N.

Cancer Lett. 2003 Sep 10;199(1):69-73.

PMID:
12963125
7.

Expression of the sodium iodide symporter and thyroglobulin genes are reduced in papillary thyroid cancer.

Ringel MD, Anderson J, Souza SL, Burch HB, Tambascia M, Shriver CD, Tuttle RM.

Mod Pathol. 2001 Apr;14(4):289-96.

8.

Proteomic identification of new biomarkers and application in thyroid cytology.

Torres-Cabala C, Bibbo M, Panizo-Santos A, Barazi H, Krutzsch H, Roberts DD, Merino MJ.

Acta Cytol. 2006 Sep-Oct;50(5):518-28.

PMID:
17017437
9.

Galectin-3 and laminin expression in neoplastic and non-neoplastic thyroid tissue.

Fernández PL, Merino MJ, Gómez M, Campo E, Medina T, Castronovo V, Sanjuán X, Cardesa A, Liu FT, Sobel ME.

J Pathol. 1997 Jan;181(1):80-6.

PMID:
9072007
10.

The use of a combination of Ki-67, Galectin-3, and PTTG can distinguish the benign and malignant thyroid tumor.

Cui W, Lu X, Zheng S, Ma Y, Liu X, Zhang W.

Clin Lab. 2012;58(5-6):419-26.

PMID:
22783570
11.

[Expression and clinical significance of galectin-3 in well-differentiated thyroid carcinoma].

Ouyang D, Chen FJ, Wei MW, Yang AK, Chen ZQ, Li QL, Chen YF.

Ai Zheng. 2005 Nov;24(11):1367-71. Chinese.

PMID:
16552965
12.

Expression of galectin-3 in fine-needle aspirates as a diagnostic marker differentiating benign from malignant thyroid neoplasms.

Inohara H, Honjo Y, Yoshii T, Akahani S, Yoshida J, Hattori K, Okamoto S, Sawada T, Raz A, Kubo T.

Cancer. 1999 Jun 1;85(11):2475-84.

PMID:
10357421
13.
14.

Usefulness of galectin-3 immunohistochemistry in differential diagnosis between thyroid follicular carcinoma and follicular adenoma.

Jakubiak-Wielganowicz M, Kubiak R, Sygut J, Pomorski L, Kordek R.

Pol J Pathol. 2003;54(2):111-5.

PMID:
14575419
15.

Immunohistochemical expression of HBME-1 and galectin-3 in the differential diagnosis of follicular-derived thyroid nodules.

Abd-El Raouf SM, Ibrahim TR.

Pathol Res Pract. 2014 Dec;210(12):971-8. doi: 10.1016/j.prp.2014.06.010. Epub 2014 Jun 27.

PMID:
25041837
16.

Evaluation of insulin-like growth factor II, cyclooxygenase-2, ets-1 and thyroid-specific thyroglobulin mRNA expression in benign and malignant thyroid tumours.

Fuhrer D, Eszlinger M, Karger S, Krause K, Engelhardt C, Hasenclever D, Dralle H, Paschke R.

Eur J Endocrinol. 2005 May;152(5):785-90.

17.

Galectin-3 is a presurgical marker of human thyroid carcinoma.

Orlandi F, Saggiorato E, Pivano G, Puligheddu B, Termine A, Cappia S, De Giuli P, Angeli A.

Cancer Res. 1998 Jul 15;58(14):3015-20.

18.
19.

Differential expression of galectin-3 in papillary projections of malignant and non-malignant hyperplastic thyroid lesions.

Cvejić D, Savin S, Petrović I, Paunović I, Tatić S, Havelka M.

Acta Chir Iugosl. 2003;50(3):67-70.

PMID:
15179758
20.

Galectin-3 expression in follicular tumours: an immunohistochemical study of its use as a marker of follicular carcinoma.

Ito Y, Yoshida H, Tomoda C, Miya A, Kobayashi K, Matsuzuka F, Yasuoka H, Kakudo K, Inohara H, Kuma K, Miyauchi A.

Pathology. 2005 Aug;37(4):296-8.

PMID:
16194828
Items per page

Supplemental Content

Write to the Help Desk